4-Aminobiphenyl is a major etiological agent of human bladder cancer: Evidence from its DNA binding spectrum in human p53 gene

Carcinogenesis

Volumn 23, Issue 10, 2002, Pages 1721-1727

  Feng, Zhaohui ^a   Hu, Wenwei ^a   Rom, William N ^a   Beland, Frederick A ^b   Tang, Moon Shong ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; DNA; NUCLEOTIDE; PROTEIN P53;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CODON; CONTROLLED STUDY; CPG ISLAND; DNA ADDUCT; DNA BINDING; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; METABOLISM; METABOLITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; URINARY TRACT CANCER;

EID: 0036797382     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.10.1721     Document Type: Article

References (40)

1. IARC (1986) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Tobacco Smoking. IARC Scientific Publications, Vol. 38, IARC, Lyon.
2. Haugen, D.A., Peak, M.J. and Suhrbler, K.M. (1982) Isolation of mutagenic aromatic amines from coal conversion oil by cation exchange chromatography. Anal. Chem., 54, 32-37.
3. Steineck, G., Plato, N., Norell, S.E. and Hogstedt, C. (1990) Urothelial cancer and some industry-related chemicals: an evalutation of the epidemiologic literature. Am. J. Ind. Med., 17, 371-391.
4. Schulte, P.A., Ward, E., Boeniger, M. and Mills, B. (1988) Occupational exposure to N-substituted aryl compounds. In King, C.M., Romano, L.J. and Schuetzle, D. (eds) Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes. Elsevier Press, New York, p. 23.
5. Vineis, P. (1994) Epeidemiology of cancer from exposure to arylamines. Environ. Health. Perspect., 102 (suppl. 6), 7-10.
6. Mommsen, S. and Aagaard, J. (1983) Tobacco as a risk factor in bladder cancer. Carcinogenesis, 4, 335-338.
7. Parkes, H.G., and Evans, A.E.J. (1984) Epidemiology of aromatic amine cancers. In Searle,C.E. (ed.) Chemical Carcinogens, 2nd Edn. American Chemical Society, Washington DC, Vol. 1, pp. 277-301.
8. Talaska, G., Al-Juburi, A.Z.S.S. and Kadlubar, F.F. (1991) Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: Identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyI as a major adduct. Proc. Natl Acad. Sci. USA, 88, 5350-5354.
9. Bryant, M.S., Skipper, P.L., Tannenbaum, S.R. and Maclure, M. (1987) Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res., 47, 602-608.
10. Beland, F.A., Beranek, D.T., Dooley, K.L., Heflich, R.H. and Kadlubar, F.F. (1983) Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect., 49, 125-134.
11. Poirier, M.C., Fullerton, N.F., Smith, B.A. and Beland, F.A. (1995) DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis, 16, 2917-2921.
12. al-Atrash, J., Zhang, Y.J., Lin, D., Kadlubar, F.F. and Santella, R.M. (1995) Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. Chem. Res. Toxicol., 8, 747-752.
13. Bartsch, H., Malaveille, C., Friesen, M., Kadlubar, F.F. and Vineis, P. (1993) Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur. J. Cancer, 29A, 1199-1207.
14. Curigliano, G., Zhang, Y.J., Wang, L.Y., Flamini, G., Alcini, A., Ratto, C., Giustaachchini, M., Alcini, E., Cittadini, A., and Santella, R.M. (1996) Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis, 17, 911-916.
15. Romano, G., Garagnani, L., Boninsegna, A. et al. (1999) Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma. Anticancer Res., 19, 4571-4576.
16. Kadlubar, F.F., Beland, F.A., Beranek, D.T., Dooley, K.L., Heflich, R.H. and Evans, F.E. (1982) Arylamine-DNA adduct formation in relation to urinary bladder carcinogenesis and Salmonella typhimurium mutagenesis. In Sugimura,T., Kondo,S. and Takebe, H. (eds) Environmental Mutagens and Carcinogens. Alan R.Liss Press, New York, pp. 385-396.
17. Greenbaltt, M.S., Bennett, W.P, Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
18. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R. and Harris, C.C. (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146.
19. Pfeifer, G.P. and Denissenko, M.F. (1998) Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations? Environ. Mol. Mutagen., 31, 197-205.
20. Hainaut, P. and Pfeifer, G.P. (2001) TP53 mutational spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Carcinogenesis, 22, 367-374.
21. Denissenko, M.F., Pao, A., Tang, M.-s. and Pfeifer, G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-432.
22. Smith, L.E., Denissenko, M.F., Bennett, W.P., Li, H., Amin, S., Tang, M.-s. and Pfeifer, G.P. (2000) Targeting of lung cancer mutational hotspot by polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst., 92, 803-811.
23. Feng, Z., Hu, W., Rom, W.N., Beland, F.A. and Tang, M.-S. (2002) NHydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation. Biochemistry, 41, 6414-6421.
24. Beland, F.A., Doerge, D.R., Churchwell, M.I., Poirier, M.C., Schoket, B. and Marques, M.M. (1999) Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem. Res. Toxicol., 12, 68-77.
25. Sancar, A. and Rupp, W.D. (1993) A novel repair enzyme: UVRABC excision nuclease of Escherichia coli cuts a DNA strand on both sides of the damaged region. Cell, 32, 249-260.
26. Tang, M.-S. (1996) Mapping and quantification of bulky-chemical-induced DNA damage using UvrABC nucleases. In PfeiferG. (ed.) Technologies for Detection of DNA Damage and Mutations. Plenum Press, New York, pp. 139.
27. Maxam, A.M. and Gilbert, W. (1980) Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol., 65, 499-560.
28. Talaska, G., Schamer, M., Skipper, P., Tannenbaum, S., Caporaso, N., Unruh, L., Kadlubar, F.F., Bartsch, H., Malaveille, C. and Vineis, P. (1991) Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers. Prev., 1, 61-66.
29. Lin, D., Lay, J.O. Jr, Bryant, M.S., Malaveille, C., Friesen, M., Bartsch, H., Lang, N.P. and Kadlubar, F.F. (1994) Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ. Health Perspect., 102 (suppl. 6), 11-16.
30. Heflich, R.H., Djuric, Z., Zhuo, Z., Fullerton, N.F, Casciano, D.A. and Beland,F.A. (1988) Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay. Environ. Mol. Mutagen., 11, 167-181.
31. Pfeifer, G.P., Drouin, R., Riggs, A.D. and Holmquist, G.R (1992) Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol. Cell. Biol., 12, 1798-1804.
32. Tornaletti, S. and Pfeifer, G.P. (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene, 10, 1493-1499.
33. Denissenko, M.F., Chen, J.X., Tang, M.-S. and Pfeifer, G.P. (1997) Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc. Natl Acad. Sci. USA, 94, 3893-3898.
34. Chen, J.X., Zheng, Y., West, M. and Tang, M.-S. (1998) Carcinogens prefrentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res., 58, 2070-2075.
35. Tang, M.-S., Zheng, J.B., Denissenko, M.F., Pfeifer, G.P. and Zheng, Y. (1999) Use of UvrABC nuclease to quantify bezo[a]pyrene diol epoxide-DNA adduct formation at methylated CpG sites in the p53 gene. Carcinogenesis, 20, 1085-1089.
36. Denissenko, M.F., Pao, A., Pfeifer, G.P. and Tang, M.-S. (1998) Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene, 16, 1241-1247.
37. Denissenko, M.F., Koudriakova, T.B., Smith, L., O'Connor, T.R., Riggs, A.D. and Pfeifer, G.P. (1998) The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene, 17, 3007-3014.
38. Ponchel, F., Puisieux, A., Tabone, E., Michot, J.P., Froschl, G., Morel, A.P., Frebourg, T., Fontaniere, B., Oberhammer, F. and Ozturk, M. (1994) Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res., 54, 2064-2068.
39. 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat. Res., 378, 97-112.
40. Hoffmann, D. and Hecht, S.S. (1990) Advances in tobacco carcinogenesis. In Cooper, C.S. and Grover, P.L. (eds) Handbook of Experimental Pharmacology. Springer-Verlag Press, Heidelberg, Vol. 94/I, pp. 63-102.